Company Name:
Island Pharmaceuticals Limited
Business Description:
Island Pharmaceuticals (ASX: ILA) is a drug repurposing company, focused on areas of unmet need for antiviral therapeutics to address infectious diseases.
Established:
Island Pharmaceuticals Limited (ILA) was listed on the Australian Stock Exchange on 13 April 2021. Island Pharmaceuticals was incorporated on 25 May 2020.
Listings:
Australian Securities Exchange (ASX code: ILA)
Registered Office:
Suite 1.01, 117 Camberwell Road
Hawthorn East, Victoria, Australia 3123
Share Registry:
Automic Registry Services
Level 5, 126 Phillip Street, Sydney, NSW, Australia, 2000
Telephone:
1300 288 664 (within Australia)
+61 2 9698 5414 (outside Australia)
Facsimile: +61 2 8583 3040
Directors:
Dr. David Foster – Managing Director – CEO
Mr Chris Ntoumenopoulos – Non Executive Director
Mr Jason Caroll – Non Executive Chair
Chief Financial Officer:
Mr Cameron Jones
Auditor:
Mr William Buck
Investor Relations:
Henry Jordan
Six Degrees Investor Relations
Email: henry.jordan@sdir.com.au
Telephone: +61 (0) 431 271 538
Website:
www.islandpharmaceuticals.com
Contact Island Pharmaceuticals:
info@islandpharmaceuticals.com